Recommended immunization schedules: Canadian Immunization Guide

For health professionals

Last partial content update (see Table of Updates): January 2020

This chapter was updated to align with changes made to Herpes Zoster (Shingles) Vaccine Chapter in Part 4 based on NACI's Updated Recommendations on the Use of Herpes Zoster Vaccines.

On this page

General recommendations

Administration of vaccines in accordance with the immunization schedules summarized in the following tables will provide optimal protection from vaccine preventable diseases for most individuals. However, modifications of the recommended schedule may be necessary due to missed appointments or illness. In general, interruption of an immunization series does not require restarting the vaccine series, regardless of the interval between doses. Individuals with interrupted immunization schedules should be vaccinated to complete the appropriate schedule for their current age. Refer to Timing of vaccine administration in Part 1 and vaccine-specific chapters in Part 4 for additional information.

Similar, but not identical, vaccines may be available from different manufacturers; therefore, it is useful to review the relevant vaccine-specific chapters in the Canadian Immunization Guide as well as the manufacturer's product leaflet or product monograph before administering a vaccine. Refer to Principles of vaccine interchangeability in Part 1 for information about the interchangeability of similar vaccines from different manufacturers. Product monographs are periodically updated; it is a best practice to consult the information contained within the product monographs available through Health Canada's Drug Product Database.

Table 1: Routine childhood immunization schedule, infants and children (birth to 17 years of age)

Table 1: Routine childhood immunization schedule, infants and children (birth to 17 years of age)
VaccineFootnote * Age
Birth 2 mos 4 mos 6 mos 12 mos 15 mos 18 mos 23 mos 2 years 4 years 5 years 6 years 9 years 12 years 14 years 15 years 16 years 17 years
DTaP-IPV-Hib
or
DTaP-HB-IPV-Hib
- Table 1 - Footnote A
or Table 1 - Footnote B
1st dose
Table 1 - Footnote A
or Table 1 - Footnote B
2nd dose
Table 1 - Footnote A
or Table 1 - Footnote B
3rd dose
Table 1 - Footnote A
or 4th dose
Generally at 18 months of age
- - - - - - - - - -
DTaP-IPV
or
Tdap-IPV
- - - - - - - - - Table 1 - Footnote C - - - - - -
Tdap - - - - - - - - - - - - - - Table 1 - Footnote D -
Rot - Table 1 - Footnote E
2 or 3 doses
Complete series before 8 months
- - - - - - - - - - - - - -
Pneu-C-13 - Table 1 - Footnote F Table 1 - Footnote F - - - - - - - - - - - -
Men-C-C - Table 1 - Footnote [G]
According to P/T schedule
Table 1 - Footnote G
Generally at 12 months
- - - - - - - -
Men-C-C
or
Men-C-ACYW
- - - - - - - - - - - - - Table 1 - Footnote H - - - -
MMR and Var - - - - Table 1 - Footnote I + Table 1 - Footnote J Table 1 - Footnote I + Table 1 - Footnote J - - - - - -
OR
MMRV - - - - Table 1 - Footnote K Table 1 - Footnote K
Generally at 4-6 years
- - - - - -
HB Table 1 - Footnote L
3 doses
- - - - - - - - - - - - -
OR
HB - - - - - - - - - - - - Table 1 - Footnote M
2 or 3 doses
HPV - - - - - - - - - - - - Table 1 - Footnote N
2 or 3 doses
- - -
OR
HPV - - - - - - - - - - - - - - - Table 1 - Footnote O
3 doses
Inf - - - Table 1 - Footnote P
1 or 2 doses
Recommended annually
Table 1 - Footnote P
1 dose
Recommended annually

Table 2: Recommended Immunization Schedule, Children (less than 7 years of age), NOT Previously Immunized as Infants

Table 2: Recommended immunization schedule, children (less than 7 years of age), not previously immunized as Infants
VaccineFootnote * First visit Time after first visit 6-12 mos
after last dose
4 weeks 8 weeks 3 mos 4 mos 6 mos
DTaP-IPV-Hib
or
DTaP-IPV
Footnote A - Footnote A - Footnote A - Footnote A Footnote [B]
Pneu-C-13 Footnote [C] - Footnote [C] - - - -
Men-C-C Footnote D - - - - - -
MMR Footnote E Footnote E - - - - -
Var Footnote F - - Footnote F - - -
OR
MMRV Footnote G - - Footnote G - - -
HB Footnote [H] Footnote [H] - - - Footnote [H] -
Inf Footnote I Footnote I - - - - -

Table 3: Recommended immunization schedule, children (7 to 17 years of age), not previously immunized

Table 3: Recommended immunization schedule, children (7 to 17 years of age), not previously immunized
VaccineFootnote * First visit Time after first visit 6-12 mos after last dose 10 yrs after last dose
4 weeks 8 weeks 3 mos 6 mos
Tdap-IPV
Tdap
Footnote A - Footnote A   - Footnote A Footnote B
Men-C-C Footnote [C]
7-11 years of age
- - - - - -
OR
Men-C-C
or
Men-C-ACYW
Footnote D
12-17 years of age
- - - - - -
MMR Footnote E Footnote E - - - - -
Var Footnote F - - - Footnote F - -
OR
MMRV Footnote G
7-12 years of age
- - Footnote G - - -
HB Footnote H Footnote [H] - - Footnote H - -
HPV Footnote I
9-14 years of age
- - - Footnote I - -
OR
HPV Footnote I
9-14 years of age
3 doses
- -
OR
HPV Footnote J
15-17 years of age
3 doses
- -
Inf Footnote K
7-8 years of age
Footnote K - - - - -
OR
Inf Footnote K
9-17 years of age
- - - - - -

Table 4: Additional recommended immunizations, children (birth to 17 years of age), considered at risk due to underlying medical conditions

Table 4: Additional recommended immunizations, children (birth to 17 years of age), considered at risk due to underlying medical condition
VaccineFootnote * Age
Birth 2 mos 6 mos 12 mos 15 mos 18 mos 23 mos 2 years 3 years 5-8 yrs 9-17 yrs
Hib - - - - - - - - - Footnote A
1 dose
Pneu-P-23 - - - - - - - Footnote B
1 dose + 1 booster dose if at highest risk
Pneu-C-13 - - Footnote C - - - - - Footnote [C]
If not previously received
Men-C-ACYW - Footnote D
2, 3 or 4 doses + additional booster doses
-
4CMenB - Footnote E
2, 3 or 4 doses + additional booster doses
HA - - - Footnote F
2 doses
HB Footnote G
3 or 4 doses
Inf - - Footnote H
1 or 2 doses
Recommended annually
Footnote H
1 dose
Recommended annually

Table 5: Recommended immunization schedule, adults (18 years of age and older), not previously immunized

Table 5: Recommended immunization schedule, adults (18 years of age and older), not previously immunized
VaccineFootnote * First visit Time after First visit 6-12 mos after last dose 10 years after last dose
4 weeks 6 weeks 8 weeks 6 mos
Tdap-IPV
Td-IPV
Td
Footnote A - - Footnote B - Footnote B Footnote C
MMR Footnote [D] - - - - - -
Var Footnote [E]
18-49 years of age
- Footnote [E] - - - -
OR
RZV Footnote [F]
50 years of age and over
- - Footnote [F] - - -
LZV Footnote [G]50 years of age and over - - - - - -
Pneu-P-23 Footnote [H] - - - - - -
Men-C-C
or
Men-C-ACYW
Footnote [I]
18-24 years of age
- - - - - -
HPV Footnote J
3 doses
- -
Inf Footnote K
Annually

Table 6: Recommended immunizations, adults (18 years of age and older), previously immunized

Table 6: Recommended immunizations, adults (18 years of age and older), previously immunized
VaccineFootnote * Age
18-26 years 27-49 years 50-59 years 60 years 65 years and older
Td Footnote A
1 dose every 10 years
Tdap Footnote B
1 dose
Pneu-P-23 - - - - Footnote C
1 dose
RZV - - Footnote D
2 doses
Inf Footnote E
Annually

Table 7: Additional recommended immunizations, adults (18 years of age and older), considered at risk

Table 7: Additional recommended immunizations, adults (18 years of age and older), considered at risk
VaccineFootnote * Age
18 years of age and older
Hib Footnote A
1 dose
IPV Footnote B
1 booster dose
MMR Footnote C
Second dose
Pneu-C-13 Footnote D
1 dose
Pneu-P-23 Footnote E
1 dose + 1 booster dose if at highest risk
Men-C-ACYW Footnote F
2 doses + booster doses
4CMenB Footnote G
2 doses
HA Footnote H
2 doses
HB Footnote I
3 or 4 doses
OR
HAHB Footnote J
3 or 4 doses
Inf Footnote K
Annually
Typh-I Footnote L
1 dose + booster doses if at ongoing risk
OR
Typh-O Footnote L
4 doses + booster doses if at ongoing risk
Rab Footnote M
3 doses + booster doses if required
Var Footnote N
2 doses
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: